ClinicalTrials.gg
Not yet recruitingNCT07945054Updated Nov 18, 2026

An Evaluation of the Usefulness, Quality, and Reliability of YouTube®-Based Exercise Videos

An observational study in Charcot Marie Tooth Disease (CMT), sponsored by Artvin Coruh University. Not yet recruiting at 1 site in Turkey (Türkiye). Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Artvin Coruh University · Observational

Updated Nov 18, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
70
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-18

Among 11 studies in Charcot-Marie-Tooth Disease with a site in Turkey — 1 open to participants now, 1 under way, none of them phase 3. Charcot-Marie-Tooth Disease · Turkey.

Started
2027
the only one that year
Observational
2 of 11
1 open now
Registered
11th of 11
by date
Lead sponsor
1 of 11
Artvin Coruh University

Among the 11 studies in Charcot-Marie-Tooth Disease with a site in Turkey, this one is the only one that started in 2027, is one of 2 observational ones, and was the 11th registered.

Charcot-Marie-Tooth Disease

115 studies on the registry are indexed under Charcot-Marie-Tooth Disease; 39 are open to participants now.

Browse Charcot-Marie-Tooth Disease studies →

Open to participants now

1 of the 11 studies in Charcot-Marie-Tooth Disease with a site in Turkey is open now.

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 31 Charcot-Marie-Tooth Disease studies recruiting now, 14 (45%) set no upper age limit and 13 (42%) stop at 75 or younger; 14 take children under 18; 13 take healthy volunteers.

This study: all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Charcot-Marie-Tooth Disease with a site in Turkey, or all of them as a file.
02

Study summary

Objective: Evaluate the reliability and quality of YouTube® information and exercise videos about Charcot-Marie-Tooth (CMT) disease.

Read the detailed description

Methods: In January 2027, an English-language YouTube search will use "Charcot-Marie-Tooth exercises." Videos will be categorized by content and upload source. Information reliability will be assessed with modified DISCERN (mDISCERN); quality will be rated using the Global Quality Scale (GQS) and JAMA criteria. Two neurological rehabilitation physical therapists will independently assess each video. A third evaluator will resolve disagreements and make the final decision.

03

Conditions studied

  • Charcot Marie Tooth Disease (CMT)

Keywords

  • Exercise
  • Charcot Marie Tooth Disease
  • Digital Health
  • Rehabilitation
04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Videos about CMT disease will be included in the study.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Include English videos primarily about CMT and exercise with acceptable audiovisual quality.

Exclusion criteria

Exclusion Criteria:

  • Exclude unrelated videos, duplicates, copies, and content solely intended for promotion.
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
70 participants (estimated)
Patient registry
No

Groups and cohorts

  • Videos about Charcot-Marie-Tooth disease

    YouTube exercise videos about Charcot-Marie-Tooth disease will be included in the study.

06

What researchers measure

Primary outcomes

  1. A modified 5-point DISCERN (mDISCERN)

    Video reliability will be assessed with the modified DISCERN (mDISCERN), a valid and reliable tool for online health information (Cronbach's alpha = 0.777; ICC = 0.823, p \< 0.001). It retains the original framework and rates each item on a 5-point Likert scale, coded as 1 ("yes") or 0 ("no"). Higher scores indicate more reliable video-based health information.

    Time frame: Single assessment at enrollment

  2. Global Quality Scale (GQS)

    Video quality will be assessed with a 5-point GQS: scores of 1-2 indicate low quality, 3 moderate quality, and 4-5 high quality. Higher scores indicate better quality. The GQS shows high inter- and intra-rater reliability: inter-rater agreement was high (Cohen's κ = 0.82; 95% CI: 0.78-0.86), and intra-rater ICCs were 0.87 (95% CI: 0.83-0.91) for the first rater and 0.89 (95% CI: 0.85-0.93) for the second.

    Time frame: Single assessment at enrollment

  3. Journal of the American Medical Association (JAMA)

    Video quality will also be assessed using the 4-point JAMA scale, which evaluates authorship, citation, information, and timeliness. Higher scores indicate better quality.

    Time frame: Single assessment at enrollment

07

Study locations

1 site
  • Zeynep Yıldız Kızkın
    Artvin, 08000, Turkey (Türkiye)
08

References and documents

Publications

  • Silberg WM, Lundberg GD, Musacchio RA. Assessing, controlling, and assuring the quality of medical information on the Internet: Caveant lector et viewor--Let the reader and viewer beware. JAMA. 1997 Apr 16;277(15):1244-5. No abstract available. PubMed 9103351 ↗
  • Tezcan H, Akyildiz Tezcan E. Assessing the Quality and Reliability of Cardiac Rehabilitation Information on YouTube: A Systematic Evaluation. Cureus. 2024 Jun 20;16(6):e62752. doi: 10.7759/cureus.62752. eCollection 2024 Jun. PubMed 38912080 ↗
  • Erkin Y, Hanci V, Ozduran E. Evaluation of the reliability and quality of YouTube videos as a source of information for transcutaneous electrical nerve stimulation. PeerJ. 2023 Jul 21;11:e15412. doi: 10.7717/peerj.15412. eCollection 2023. PubMed 37492399 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Jan 2027; primary completion for Jan 2027, 0 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 12, 2026
First posted
Nov 18, 2026
StartEst.
Jan 1, 2027
Primary completionEst.
Jan 15, 2027
CompletionEst.
Feb 1, 2027
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07945054
Lead sponsor
Artvin Coruh University
Responsible party
Zeynep Yıldız Kızkın (Lecturer, Artvin Coruh University) — Principal investigator
First posted
Nov 18, 2026
Start date
Jan 1, 2027 (estimated)
Primary completion
Jan 15, 2027 (estimated)
Completion
Feb 1, 2027 (estimated)
Last update
Nov 18, 2026

Study contacts

Zeynep Yıldız Kızkın
Contact
pt.zeynepyildiz@gmail.com
+90 ext. 5346945085
Zeynep Yıldız Kızkın
principal investigator · Artvin Coruh University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion